Product Documentation for Luminex and Licensed Technologies

White Papers - English

Clinical Impact After Laboratory Implementation of the Verigene Gram-Negative Bacteria Microarray for Positive Blood Cultures

Download (458.24 KB)

White Papers - English

Clinical Performance of the Luminex VERIGENE® Respiratory Pathogens Flex Nucleic Acid Test as Compared to the BioFire® FilmArray® Respiratory Panel

Download (453.08 KB)

White Papers - English

CYP2C19 Testing: An Opportunity to Improve Patient Care

Download (177.32 KB)

White Papers - English

Evaluation of Costs, Technologists Time, and Turn-Around Times for Conventional Stool Cultures

Download (791.79 KB)

White Papers - English

Flexible Respiratory Pathogen Testing: Why Clinical Laboratories No Longer Have to Settle

Download (419.5 KB)

White Papers - English

For Bloodstream Infections, Rapid Molecular Testing Improves Patient Outcomes and Lowers Costs

Download (274.96 KB)

White Papers - English

Limit of Detection Study for the NxTAG® Respiratory Pathogen Panel Demonstrates Sensitivity of 102 to 104 Gene Copies/ml (EU Only)

Download (281.87 KB)

White Papers - English

Molecular Tests Provide a Better Alternative to Stool Culture for GI Cases

Download (292.51 KB)

White Papers - English

Respiratory Infection Testing Requires Flexible, Cost-Effective Diagnostics

Download (233.78 KB)

White Papers - English

Licensed Technologies and Luminex Product Documentation

Clinical Impact After Laboratory Implementation of the Verigene Gram-Negative Bacteria Microarray for Positive Blood Cultures

Clinical Performance of the Luminex VERIGENE® Respiratory Pathogens Flex Nucleic Acid Test as Compared to the BioFire® FilmArray® Respiratory Panel

CYP2C19 Testing: An Opportunity to Improve Patient Care

Evaluation of Costs, Technologists Time, and Turn-Around Times for Conventional Stool Cultures

Flexible Respiratory Pathogen Testing: Why Clinical Laboratories No Longer Have to Settle

For Bloodstream Infections, Rapid Molecular Testing Improves Patient Outcomes and Lowers Costs

Limit of Detection Study for the NxTAG® Respiratory Pathogen Panel Demonstrates Sensitivity of 102 to 104 Gene Copies/ml (EU Only)

Molecular Tests Provide a Better Alternative to Stool Culture for GI Cases

Respiratory Infection Testing Requires Flexible, Cost-Effective Diagnostics

Time and Motion Study: Molecular Testing with VERIGENE® Enteric Pathogens (EP) Test Accelerates Results for GI Infection Samples

xPONENT 3.1 Logistic Curve Fitting White Paper

xTAG Gastrointestinal Pathogen Panel – The Value of Molecular GI Testing

Licensed Technologies and Luminex Product Documentation

1. Product type

2. Product category

3. Product

4. Document Type

Clinical Impact After Laboratory Implementation of the Verigene Gram-Negative Bacteria Microarray for Positive Blood Cultures

Clinical Performance of the Luminex VERIGENE® Respiratory Pathogens Flex Nucleic Acid Test as Compared to the BioFire® FilmArray® Respiratory Panel

CYP2C19 Testing: An Opportunity to Improve Patient Care

Evaluation of Costs, Technologists Time, and Turn-Around Times for Conventional Stool Cultures

Flexible Respiratory Pathogen Testing: Why Clinical Laboratories No Longer Have to Settle

For Bloodstream Infections, Rapid Molecular Testing Improves Patient Outcomes and Lowers Costs

Limit of Detection Study for the NxTAG® Respiratory Pathogen Panel Demonstrates Sensitivity of 102 to 104 Gene Copies/ml (EU Only)

Molecular Tests Provide a Better Alternative to Stool Culture for GI Cases

Respiratory Infection Testing Requires Flexible, Cost-Effective Diagnostics

Time and Motion Study: Molecular Testing with VERIGENE® Enteric Pathogens (EP) Test Accelerates Results for GI Infection Samples

xPONENT 3.1 Logistic Curve Fitting White Paper

xTAG Gastrointestinal Pathogen Panel – The Value of Molecular GI Testing